%0 Journal Article
%A Afshar-Oromieh, Ali
%A Vollnberg, Bernd
%A Alberts, Ian
%A Bähler, Alexandrine
%A Sachpekidis, Christos
%A Dijkstra, Lotte
%A Haupt, Fabian
%A Boxler, Silvan
%A Gross, Tobias
%A Holland-Letz, Tim
%A Thalmann, George
%A Heverhagen, Johannes
%A Rominger, Axel
%A Härmä, Kirsi
%A Maurer, Martin H
%T Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis.
%J European journal of nuclear medicine and molecular imaging
%V 46
%N 11
%@ 1619-7089
%C Heidelberg [u.a.]
%I Springer-Verl.
%M DKFZ-2019-01888
%P 2289-2297
%D 2019
%X So far, there have been very few studies which provide a direct comparison between MRI and PSMA-ligand PET/CT for the detection of recurrent prostate cancer (rPC). This present study therefore aims to provide further clinical data in order to resolve this urgent clinical question, and thereby strengthen clinical recommendations.A retrospective analysis was performed for patients who were scanned at our institution with whole-body PSMA-PET/CT (tracer: 68Ga-PSMA-11) between January 2017 and September 2018 in order to detect rPC. Amongst them, 43 underwent an additional pelvic MRI within 2 months. Both modalities were compared as follows: a consensus read of the PET data was performed by two nuclear physicians. All lesions were recorded with respect to their type and localization. The same process was conducted by two radiologists for pelvic MRI. Thereafter, both modalities were directly compared for every patient and lesion.Overall, 30/43 patients (69.8
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31350604
%R 10.1007/s00259-019-04438-w
%U https://inrepo02.dkfz.de/record/144436